The antiviral drug Paxlovid can reduce the severity of COVID-19, and now, women can rest assured that they can safely take the drug during pregnancy without risking harm to themselves or their unborn babies.
makes a strong case that people who are pregnant and have been infected with SARS-CoV-2, the virus that causes COVID-19, can safely take the antiviral drug Paxlovid to reduce the possibility of severe disease.particularly susceptible to infections, and in the case of COVID-19 research shows they are more likely to experience severe symptoms and require hospitalization, making the drug particularly beneficial in the pregnant population.
Paxlovid consists of two medicines: nirmatrelvir, an antiviral agent that inhibits a key enzyme that the SARS-CoV-2 virus needs to reproduce inside the body, and ritonavir, a drug that boosts the effectiveness of nirmatrelvir by slowing its elimination, so it remains in the bloodstream for longer periods of time.The drug is prescribed for adults and children aged 12 years and older infected with SARS-CoV-2 and at high risk for progression to severe COVID, including hospitalization and death.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Protecting yourself against COVID-19 during the holidays - New York Amsterdam NewsAs we approach the third anniversary of the beginning of the COVID-19 pandemic, we are faced with COVID fatigue, conflicting information and the false idea that the pandemic is now over. So with the third holiday season of the COVID-19 pandemic in full swing, there are many lingering questions regarding COVID safety. Do I still […]
Read more »
Severe COVID Looks Scarily Like Old Age in The Human Brain, Study FindsSevere COVID-19 looks scarily like old age in the human brain, according to a postmortem analysis of 54 healthy and infected individuals.
Read more »
Shocking Study Finds Severe COVID-19 Linked With Molecular Signatures of Brain AgingScientists emphasize the value of neurological follow-up in recovered individuals. It's true that COVID-19 is primarily a respiratory disease. However, neurological symptoms have been described in many COVID-19 patients, including in recovered individuals. In fact, a range of symptoms has been re
Read more »
COVID Trend That Spelled Big Trouble in 2020 Is BackThere are signs that, once again, COVID is disproportionately afflicting older people. It’s like 2020 all over again. And the seniors in one country are especially at risk: China.
Read more »
China to drop some travel tracking as it relaxes COVID rulesChina will drop a travel tracing requirement as part of an uncertain exit from its strict “zero-COVID” policies that have elicited widespread dissatisfaction.
Read more »